A carregar...
Velaglucerase alfa (VPRIV) enzyme replacement therapy in patients with Gaucher disease: Long-term data from phase III clinical trials
Type 1 Gaucher disease is an inherited lysosomal enzyme deficiency with variable age of symptom onset. Common presenting signs include thrombocytopenia, anemia, hepatosplenomegaly, bone abnormalities, and, additionally in children, growth failure. Fifty-seven patients aged 3–62 years at the baseline...
Na minha lista:
Publicado no: | Am J Hematol |
---|---|
Main Authors: | , , , , , , , , , , , , |
Formato: | Artigo |
Idioma: | Inglês |
Publicado em: |
Blackwell Publishing Ltd
2015
|
Assuntos: | |
Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4654249/ https://ncbi.nlm.nih.gov/pubmed/25801797 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/ajh.24012 |
Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|